Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chatfield

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Vaccine|April 1, 1996
Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigenL P Londoño, S Chatfield, R W Tindle, et al.
Oncology Nursing Forum|July 29, 1998
Reinfusion of discard blood from venous access devicesP A Cosca, S Smith, S Chatfield, et al.
Molecular Microbiology|November 1, 1988
Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayerB B Finlay, M N Starnbach, C L Francis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussisI G Charles, G Dougan, D Pickard, et al.
Infection and Immunity|September 19, 2000
Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigensA Bacon, J Makin, P J Sizer, et al.
Journal of General Microbiology|January 1, 1991
Molecular cloning and characterization of the aroD gene encoding 3-dehydroquinase from Salmonella typhiS Servos, S Chatfield, D Hone, et al.
Infection and Immunity|October 1, 1996
Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908E M Barry, O Gomez-Duarte, S Chatfield, et al.
Infection and Immunity|October 1, 1992
Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussisR Strugnell, G Dougan, S Chatfield, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Behring Institute Mitteilungen|February 1, 1997
Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectorsM M Levine, J Galen, E Barry, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Vaccine|April 1, 1996
Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigenL P Londoño, S Chatfield, R W Tindle, et al.
Oncology Nursing Forum|July 29, 1998
Reinfusion of discard blood from venous access devicesP A Cosca, S Smith, S Chatfield, et al.
Molecular Microbiology|November 1, 1988
Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayerB B Finlay, M N Starnbach, C L Francis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussisI G Charles, G Dougan, D Pickard, et al.
Infection and Immunity|September 19, 2000
Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigensA Bacon, J Makin, P J Sizer, et al.
Journal of General Microbiology|January 1, 1991
Molecular cloning and characterization of the aroD gene encoding 3-dehydroquinase from Salmonella typhiS Servos, S Chatfield, D Hone, et al.
Infection and Immunity|October 1, 1996
Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908E M Barry, O Gomez-Duarte, S Chatfield, et al.
Infection and Immunity|October 1, 1992
Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussisR Strugnell, G Dougan, S Chatfield, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Behring Institute Mitteilungen|February 1, 1997
Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectorsM M Levine, J Galen, E Barry, et al.
Pageof 5